Education
About Us
Working with TipRanks
Follow Us
Helius Medical Technologies (HSDT)
NASDAQ:HSDT
Total Valuation
Helius Medical Technologies has a market cap or net worth of $1.96M. The enterprise value is ―.
Market Cap$1.96M
Enterprise Value―
Share Statistics
Helius Medical Technologies has 528,062 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding528,062
Owned by Insiders73.64%
Owned by Institutions<0.01%
Financial Efficiency
Helius Medical Technologies’s return on equity (ROE) is -11.09 and return on invested capital (ROIC) is -1008.19%.
Return on Equity (ROE)-11.09
Return on Assets (ROA)-3.32
Return on Invested Capital (ROIC)-1008.19%
Return on Capital Employed (ROCE)-10.08
Revenue Per Employee24.76K
Profits Per Employee-559.14K
Employee Count21
Asset Turnover0.15
Inventory Turnover0.56
Valuation Ratios
The current PE Ratio of Helius Medical Technologies is -2.32. Helius Medical Technologies’s PEG ratio is -2.97.
PE Ratio-2.32
PS Ratio0.00
PB Ratio10.67
Price to Fair Value25.72
Price to FCF-0.15
Price to Operating Cash Flow-1.02
PEG Ratio-2.97
Income Statement
In the last 12 months, Helius Medical Technologies had revenue of 520.00K and earned -11.74M in profits. Earnings per share was -4.33.
Revenue520.00K
Gross Profit-62.00K
Operating Income-13.90M
Pretax Income-11.74M
Net Income-11.74M
EBITDA-13.80M
Earnings Per Share (EPS)-4.33
Cash Flow
In the last 12 months, operating cash flow was -11.04M and capital expenditures -5.00K, giving a free cash flow of -11.05M billion.
Operating Cash Flow-11.04M
Free Cash Flow-11.05M
Free Cash Flow per Share-20.92
Dividends & Yields
Helius Medical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change-80.05%
50-Day Moving Average4.88
200-Day Moving Average8.23
Relative Strength Index (RSI)37.15
Average Volume (3m)16.95K
Important Dates
Helius Medical Technologies upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Helius Medical Technologies as a current ratio of 1.58, with Debt / Equity ratio of 1.13%
Current Ratio1.58
Quick Ratio1.10
Debt to Market Cap0.00
Net Debt to EBITDA0.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Helius Medical Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Helius Medical Technologies EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -2.37.
EV to Sales50.30
EV to EBITDA-1.90
EV to Free Cash Flow-2.37
EV to Operating Cash Flow-2.37
Balance Sheet
Helius Medical Technologies has $1.09M in cash and marketable securities with $12.00K in debt, giving a net cash position of -$1.08M billion.
Cash & Marketable Securities$1.09M
Total Debt$12.00K
Net Cash-$1.08M
Net Cash Per Share-$2.04
Tangible Book Value Per Share$0.39
Margins
Gross margin is -11.92%, with operating margin of -2673.65%, and net profit margin of -2258.08%.
Gross Margin-11.92%
Operating Margin-2673.65%
Pretax Margin-2258.08%
Net Profit Margin-2258.08%
EBITDA Margin-2654.42%
EBIT Margin-2665.96%
Analyst Forecast
The average price target for Helius Medical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-35.03%
EPS Growth Forecast59.34%